ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,958, issued on Aug. 19, was assigned to Lentigen Technology Inc. (Gaithersburg, Md.) and The U.S.A., as represented by The Secretary, Department of Health and Human Services (Bethesda, Md.).

"Compositions and methods for treating cancer with anti-CD38 immunotherapy" was invented by Dina Schneider (Potomac, Md.), Rimas J. Orentas (Seattle), Boro Dropulic (Ellicott City, Md.), Dimiter S. Dimitrov (Frederick, Md.) and Zhongyu Zhu (Frederick, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Chimeric antigen receptors containing CD38 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragme...